Arkolith/Insider Trading/CAMP/Form 4

Mandel-Brehm Josh

Chief Executive Officer, DirectorCamp4 Therapeutics Corp (CAMP) · full profile →Form 4 · filed Oct 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2024Conversion(C)605——272K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2024Conversion(C)7K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-108699) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML